Nov 10, 2021 5:00pm EST Medexus Pharmaceuticals Reports Financial and Operational Results for the Three- and Six-Month Periods Ending September 30, 2021
Nov 01, 2021 9:27am EDT Medexus Pharmaceuticals Announces Type A Meeting with FDA Granted for Treosulfan
Oct 26, 2021 8:30am EDT Medexus to Present at the Benzinga Global Small Cap Conference on October 28, 2021
Sep 16, 2021 4:30pm EDT Medexus Holds Annual and Special Meeting of Shareholders and Announces Election of Board of Directors
Sep 02, 2021 8:30am EDT Medexus Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 16, 2021 5:30pm EDT Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022
